Although inactivated immunological veterinary medicinal products referred to in Article 2(3) should be manufactured in accordance with the principles of good manufacturing practice, detailed guidelines of good manufacturing practice should specifically be prepared for those products since they are manufactured in a way that is different from industrially prepared products.
Cé gur cheart táirgí íocshláinte tréidliachta imdhíoneolaíocha díghníomhaithe dá dtagraítear in Airteagal 2(3) a mhonarú i gcomhréir le prionsabail an dea-chleachtais monaraíochta, ba cheart treoirlínte mionsonraithe maidir le dea-chleachtas monaraíochta a ullmhú go sonrach le haghaidh na dtáirgí sin ós rud é go ndéantar iad a mhonarú ar bhealach atá éagsúil ó tháirgí a ullmhaítear go tionsclaíoch.